A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Ammar AlmaaytahQosay Al-Balas

Abstract

Current research in the field of antimicrobials is focused on developing novel antimicrobial agents to counteract the huge dilemma that the human population is mainly facing in regards to the rise of bacterial resistance and biofilm infections. Host defense peptides (HDPs) are a promising group of molecules for antimicrobial development as they display several attractive features suitable for antimicrobial activity, including their broad spectrum of activity and potency against bacteria. AamAP1 is a novel HDP that belongs to the venom of the North African scorpion Androctonus amoeruxi. In vitro antimicrobial assays revealed that the peptide displays moderate activity against Gram-positive and Gram-negative bacteria. Additionally, the peptide proved to be highly hemolytic and displayed significantly high toxicity against mammalian cells. In our study, a novel synthetic peptide analogue named A3 was synthetically modified from AamAP1 in order to enhance its activity and toxicity profile. The design strategy depended on modifying the amino acid sequence of AamAP1 in order to alter its net positive charge, percentage helicity and modify other parameters that are involved theoretically in HDPs activity. Accordingly, A3 was evaluated...Continue Reading

References

Dec 5, 1993·Journal of Molecular Biology·A Sali, T L Blundell
Mar 1, 2000·Trends in Biochemical Sciences·C CombetG Deléage
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden
Jun 28, 2005·Nucleic Acids Research·Johannes SödingAndrei N Lupas
Aug 25, 2006·Biochimica Et Biophysica Acta·Burkhard Bechinger, Karl Lohner
Dec 15, 2007·Biochimica Et Biophysica Acta·David W Hoskin, Ayyalusamy Ramamoorthy
Jan 25, 2008·BMC Bioinformatics·Yang Zhang
May 20, 2009·Antimicrobial Agents and Chemotherapy·Zhenhuan ZhaoWenxin Li
Sep 22, 2009·The Journal of Infection·Neil Woodford, David M Livermore
Mar 26, 2010·Investigative Ophthalmology & Visual Science·Henri SuekeChristopher M Parry
Jun 18, 2011·Trends in Biotechnology·Leonard T NguyenHans J Vogel
Jun 19, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J M RolainG Cornaglia
Nov 5, 2013·Peptides·Ammar Almaaytah, Qosay Albalas
Aug 13, 2014·Trends in Immunology·Sarah C MansourRobert E W Hancock
Jan 16, 2015·American Journal of Respiratory and Critical Care Medicine·Brad SpellbergDavid N Gilbert
Jun 2, 2015·New Microbes and New Infections·I RocaJ Vila
Mar 24, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F-P HuW Huang
Jul 8, 2016·Pharmaceuticals·Mahadevappa HemshekharNeeloffer Mookherjee
Nov 23, 2016·Journal of Dental Research·B Bechinger, S-U Gorr
Apr 12, 2017·Current Opinion in Chemical Biology·Biswajit MishraGuangshun Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
Assay

Software Mentioned

SOPM
TASSER
HydroMCalc
HHsearch
Innovagen
HHpred ( HHsearch
NPS SOPM
Accelrys ® Discovery studio
HHpred
RAMPAGE

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.